ciprofloxacin has been researched along with acetaminophen in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.76) | 18.2507 |
| 2000's | 10 (23.81) | 29.6817 |
| 2010's | 23 (54.76) | 24.3611 |
| 2020's | 7 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Barecki, M; Casciano, CN; Clement, RP; Johnson, WW; Lew, K; Wang, E | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Avdeef, A; Tam, KY | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
| Makde, SD; Paranjpe, BD; Shrivastava, MP | 1 |
| El-Abadla, NS; Issa, MM; Nejem, RM | 1 |
| El-Abadla, NS; El-Naby, MK; Issa, MM; Kheiralla, ZA; Nejem, RM; Roshdy, AA | 1 |
| Marchessault, RH; Ravenelle, F; Thérien-Aubin, H; Zhu, XX | 1 |
| Bhanger, MI; Khuhawar, MY; Mallah, A; Memon, N; Memon, SQ; Solangi, AR | 1 |
| Arroyo, A; Calpena, R; Candela, F; Moya, P; Pérez-Legaz, J; Serrano, P; Soriano-Irigaray, L | 1 |
| Chen, F; Chen, H; Fu, W; Luo, W; Meng, F; Xie, Y; Yang, X; Ye, T; Young, K | 1 |
| Mihçiokur, H; Oğuz, M | 1 |
| Abdel-Aziz, O; El Zahar, NM; El-Kosasy, AM; Magdy, N | 1 |
| Costa E Silva, B; de Lima Perini, JA; Nogueira, RFP | 1 |
| Arroyo, A; Bellon, M; Calpena, R; Candela, F; Galindo, I; Lacueva, J; Moya, P | 1 |
| Dhodapkar, R; Kumar, A | 1 |
| Araújo Almeida, A; Fatibello-Filho, O; Martin Santos, A; Wong, A | 1 |
| Chamba, N; Dekker, MCJ; Kilonzo, KG; Kumburu, H; Mmbaga, BT; Nyombi, B; Sonda, T; Urasa, SJ; van Zwetselaar, M | 1 |
| Bridgeman, PJ; Jawaro, T; Mele, J; Wei, G | 1 |
| Correia, B; Nogueira, AF; Nunes, B; Pinto, G | 1 |
| Kumar, R; Mohan, D; Patel, M; Pittman, CU | 1 |
| Elizalde-Velázquez, GA; Gómez-Oliván, LM; Islas-Flores, H; Orozco-Hernández, JM; Raldúa, D; Rosas-Ramírez, JR | 1 |
| Elizalde-Velázquez, GA; Galar-Martínez, M; García-Medina, S; Gómez-Oliván, LM; Guzmán-García, X; Islas-Flores, H; Orozco-Hernández, JM; Raldua, D; Rosales-Pérez, K; Rosas-Ramírez, JR | 1 |
| Boncz, MÁ; López-Serna, R; Muñoz, R; Ruas, G; Scarcelli, PG; Serejo, ML | 1 |
| Alsubih, M; Balakrishnan, D; El Morabet, R; Khan, AR; Khan, NA; Khan, RA; Khan, S; Khoo, KS; Mubashir, M | 1 |
| Echavarría-Isaza, A; Lee, J; Serna-Galvis, EA; Silva-Agredo, J; Torres-Palma, RA | 1 |
| Akinsete, SJ; Egbeyemi, MM; Ewemoje, TA; Lateef, SA; Omobowale, MO | 1 |
1 review(s) available for ciprofloxacin and acetaminophen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for ciprofloxacin and acetaminophen
| Article | Year |
|---|---|
Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva.
Topics: Acetaminophen; Administration, Oral; Adult; Analgesics, Non-Narcotic; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Half-Life; Humans; Metabolic Clearance Rate; Saliva | 2006 |
Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Area Under Curve; Biological Assay; Calibration; Ciprofloxacin; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Serum Bactericidal Test | 2007 |
39 other study(ies) available for ciprofloxacin and acetaminophen
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
Topics: 3T3 Cells; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Mice; Microsomes, Liver; Mixed Function Oxygenases; Molecular Structure; Substrate Specificity | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Interaction of ciprofloxacin with diclofenac and paracetamol in relation to it's epileptogenic effect.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Drug Synergism; Female; gamma-Aminobutyric Acid; Male; Mice; Seizures | 1997 |
Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
Topics: Acetaminophen; Amylose; Ciprofloxacin; Cross-Linking Reagents; Delayed-Action Preparations; Diffusion; Drug Carriers; Kinetics; Magnetic Resonance Spectroscopy; Membrane Fusion; Starch; Tablets; Water | 2008 |
Development and implication of a capillary electrophoresis methodology for ciprofloxacin, paracetamol and diclofenac sodium in pharmaceutical formulations and simultaneously in human urine samples.
Topics: Acetaminophen; Buffers; Calibration; Ciprofloxacin; Diclofenac; Electricity; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets; Time Factors | 2011 |
Applicability, safety and efficiency of outpatient treatment in uncomplicated diverticulitis.
Topics: Acetaminophen; Acute Disease; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Ciprofloxacin; Colonoscopy; Combined Modality Therapy; Diverticulitis; Female; Hospital Costs; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2012 |
Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China.
Topics: Acetaminophen; Caffeine; Carbamazepine; Carbon; China; Ciprofloxacin; DEET; Environmental Monitoring; Erythromycin; Nitrates; Nitrites; Nitrogen; Pharmaceutical Preparations; Quaternary Ammonium Compounds; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Water Quality | 2013 |
Environmental risk assessment of selected pharmaceuticals in Turkey.
Topics: 1-Octanol; Acetaminophen; Adsorption; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzalkonium Compounds; Cefuroxime; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Naproxen; Pharmaceutical Preparations; Risk Assessment; Sewage; Turkey; Water; Water Pollutants, Chemical | 2014 |
Spectrophotometric and chemometric methods for determination of imipenem, ciprofloxacin hydrochloride, dexamethasone sodium phosphate, paracetamol and cilastatin sodium in human urine.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Dexamethasone; Humans; Imipenem; Least-Squares Analysis; Limit of Detection; Multivariate Analysis; Principal Component Analysis; Spectrophotometry, Ultraviolet | 2016 |
Influence of dihydroxybenzenes on paracetamol and ciprofloxacin degradation and iron(III) reduction in Fenton processes.
Topics: Acetaminophen; Benzene Derivatives; Ciprofloxacin; Iron; Water Pollutants; Water Purification | 2017 |
Outpatient treatment in uncomplicated acute diverticulitis: 5-year experience.
Topics: Acetaminophen; Acute Disease; Adult; Aged; Aged, 80 and over; Ambulatory Care; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Diet Therapy; Diverticulitis; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Offline solid-phase extraction for preconcentration of pharmaceuticals and personal care products in environmental water and their simultaneous determination using the reversed phase high-performance liquid chromatography method.
Topics: Acetaminophen; Benzophenones; Caffeine; Carbanilides; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Ciprofloxacin; Cities; Cosmetics; Environmental Monitoring; India; Limit of Detection; Reproducibility of Results; Rivers; Sensitivity and Specificity; Sewage; Solid Phase Extraction; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2016 |
Simultaneous determination of paracetamol and ciprofloxacin in biological fluid samples using a glassy carbon electrode modified with graphene oxide and nickel oxide nanoparticles.
Topics: Acetaminophen; Carbon; Ciprofloxacin; Clinical Chemistry Tests; Electrochemistry; Electrodes; Glass; Graphite; Humans; Hydrogen-Ion Concentration; Limit of Detection; Nickel; Oxides; Time Factors | 2017 |
Aeromonas caviae mimicking Vibrio cholerae infectious enteropathy in a cholera-endemic region with possible public health consequences: two case reports.
Topics: Acetaminophen; Adult; Aeromonas caviae; Anti-Bacterial Agents; Cholera; Ciprofloxacin; Diagnosis, Differential; Doxycycline; Endemic Diseases; Female; Humans; Intraabdominal Infections; Metronidazole; Middle Aged; Public Health; Tanzania; Vibrio cholerae; Young Adult | 2018 |
Descriptive study of drug-drug interactions attributed to prescriptions written upon discharge from the emergency department.
Topics: Acetaminophen; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Analgesics; Ciprofloxacin; Drug Combinations; Drug Interactions; Emergency Service, Hospital; Female; Glucocorticoids; Humans; Ibuprofen; Male; Oxycodone; Patient Discharge; Prednisone; Retrospective Studies | 2019 |
Embryonic development, locomotor behavior, biochemical, and epigenetic effects of the pharmaceutical drugs paracetamol and ciprofloxacin in larvae and embryos of Danio rerio when exposed to environmental realistic levels of both drugs.
Topics: Acetaminophen; Animals; Biomarkers; Catalase; Ciprofloxacin; DNA Methylation; Embryonic Development; Epigenesis, Genetic; Glutathione Peroxidase; Larva; Lipid Peroxidation; Locomotion; Oxidative Stress; Water Pollutants, Chemical; Zebrafish | 2019 |
Ciprofloxacin and acetaminophen sorption onto banana peel biochars: Environmental and process parameter influences.
Topics: Acetaminophen; Adsorption; Charcoal; Ciprofloxacin; Musa | 2021 |
Teratogenic effects induced by paracetamol, ciprofloxacin, and their mixture on Danio rerio embryos: Oxidative stress implications.
Topics: Acetaminophen; Animals; Ciprofloxacin; Embryo, Nonmammalian; Oxidative Stress; Water Pollutants, Chemical; Zebrafish | 2022 |
Low concentrations of ciprofloxacin alone and in combination with paracetamol induce oxidative stress, upregulation of apoptotic-related genes, histological alterations in the liver, and genotoxicity in Danio rerio.
Topics: Acetaminophen; Animals; Ciprofloxacin; DNA Damage; Liver; Oxidative Stress; Up-Regulation; Water Pollutants, Chemical; Zebrafish | 2022 |
Influence of the hydraulic retention time on the removal of emerging contaminants in an anoxic-aerobic algal-bacterial photobioreactor coupled with anaerobic digestion.
Topics: Acetaminophen; Anaerobiosis; Bacteria, Aerobic; Bioreactors; Ciprofloxacin; Dexamethasone; Enrofloxacin; Ibuprofen; Naproxen; Photobioreactors; Progesterone; Sewage; Sulfamethoxazole; Tetracyclines; Trimethoprim; Tylosin; Waste Disposal, Fluid | 2022 |
Comparison of constructed wetland performance coupled with aeration and tubesettler for pharmaceutical compound removal from hospital wastewater.
Topics: Acetaminophen; Animals; Carbamazepine; Ciprofloxacin; Erythromycin; Hospitals; Ibuprofen; Lorazepam; Pharmaceutical Preparations; Simvastatin; Waste Disposal, Fluid; Wastewater; Wetlands | 2023 |
Possibilities and Limitations of the Sono-Fenton Process Using Mid-High-Frequency Ultrasound for the Degradation of Organic Pollutants.
Topics: Acetaminophen; Ciprofloxacin; Environmental Pollutants; Hydrogen Peroxide; Iron; Minerals; Oxidation-Reduction; Water Pollutants, Chemical | 2023 |
Health risk assessment for uptake and accumulation of pharmaceuticals in jute mallow (Corchorus olitorius) irrigated with treated hospital wastewater.
Topics: Acetaminophen; Agricultural Irrigation; Anti-Bacterial Agents; Ciprofloxacin; Corchorus; Diclofenac; Environmental Monitoring; Humans; Ibuprofen; Pharmaceutical Preparations; Risk Assessment; Soil; Soil Pollutants; Sulfamethoxazole; Tetracyclines; Wastewater; Water | 2023 |